Category Archives: Case Studies

Global Biosimilar Financing Opportunity

  CLIENT: Large manufacturer with significant global penetration looking to understand the threat that biosimilars pose to its biologic portfolio as well as opportunities for developing biosimilars for other products in emerging markets. BUSINESS QUESTION: What is the current regulatory, access / reimbursement and competitive landscape for biosimilars within each of the BRICKMT markets, and […]

Read more

Development of Franchise Molecular Diagnostics Strategy

CLIENT: A leading pharmaceutical company with a large oncology portfolio looking to understand the impact of molecular diagnostic test utilization on their products. BUSINESS QUESTION: How should a manufacturer support appropriate, clinically validated molecular diagnostic testing across their oncology franchise? OUR APPROACH: ISA’s Oncology & Specialty Therapeutics Team utilized their existing Molecular Diagnostics Database as […]

Read more

Access Influencer Mapping

CLIENT: A multinational pharmaceutical manufacturer looking to better understand payer management philosophies and support appropriate access for their specialty brands. BUSINESS QUESTION: How do third party stakeholders interact with and influence payer management across multiple specialty therapeutic areas? OUR APPROACH: In depth discussions were conducted with key payers and emerging access influencers including specialty practices, […]

Read more

Pathways Programs Impact Assessment

CLIENT: An industry leading biotechnology company, with a primary focus in oncology, sought to quantify the current and anticipated future impact of emerging pathways programs on their portfolio. BUSINESS QUESTION: What is the impact of pathways programs, how is this forecasted to evolve over a 3-year outlook, and how can our client maximize opportunities to […]

Read more

Specialty Distribution Model Development

CLIENT: A multinational pharmaceutical manufacturer interested in developing a distribution strategy for two specialty products in different stages of their lifecycle. BUSINESS QUESTION: What distribution strategy will allow our client to optimize specialty distribution in light of product needs, internal capabilities, and existing vendor relationships? OUR APPROACH: ISA worked closely with the client to gain […]

Read more